{"id":254243,"date":"2018-08-16T10:42:04","date_gmt":"2018-08-16T10:42:04","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=254243"},"modified":"2018-08-16T10:42:04","modified_gmt":"2018-08-16T10:42:04","slug":"drug-allergy-market-forecast-to-2023-trends-growth-factors-top-companies-and-detail-research-in-healthcare-sector","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/drug-allergy-market-forecast-to-2023-trends-growth-factors-top-companies-and-detail-research-in-healthcare-sector_254243.html","title":{"rendered":"Drug Allergy Market forecast to 2023: Trends & Growth Factors, Top Companies and Detail Research In Healthcare Sector"},"content":{"rendered":"
\"\"<\/a><\/div>\n
Drug allergy market information: by type (immunologic, nonimmunologic, and others), diagnosis (skin tests, blood tests, and others), by treatment (antihistamines, corticosteroids, and others), by end user- global forecast till 2023\n<\/div>\n

Synopsis of Global Drug Allergy Market<\/strong><\/p>\n

Market Scenario<\/strong><\/p>\n

The global drug allergy market is growing moderately and it is expected to grow with the same pace over the forecast period 2017-2018. Increasing prevalence of drug allergies and funding for research & development of the new drugs drive the global market.<\/p>\n

The global market of drug allergy was around USD 3363.2 million in 2016 and is expected to reach USD 4764.0 million by 2023 at a projected CAGR of 5.1%.<\/p>\n

Taste the market data and market information presented through more than 56 market data tables and figures spread over 84 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Drug allergy Market Research Report–Global Forecast to 2023.”<\/p>\n

Get Sample Copy @ <\/strong>https:\/\/www.marketresearchfuture.com\/sample_request\/4033<\/strong><\/a><\/p>\n

Major Key Players in the Global Drug Allergy Market             <\/strong>                              <\/p>\n

Some of the key players in this market: AstraZeneca (UK), Bayer (US), Circassia (US), HAL Allergy Group (the Netherlands), Johnson & Johnson Services, Inc. (US), MAGNA Pharmaceuticals, Inc. (US), Stallergenes Greer (UK), and others.<\/p>\n

Segments           <\/strong>                                                                                                                               <\/p>\n

The global drug allergy market is segmented on the basis of type, which comprises of immunologic, nonimmunologic, and others. Immunologic allergy is sub-segmented into type I reaction, type II reaction, type III reaction, type IV reaction, and others. The non-immunologic allergy is sub-segmented into predictable, unpredictable, and others. The predictable allergy is further segmented into pharmacologic side effect, secondary pharmacologic side effect, drug toxicity, drug-drug interactions, drug overdose, and others. The unpredictable segment is further sub-segmented into pseudoallergic, idiosyncratic, intolerance, and others.<\/p>\n

On the basis of diagnosis, the market is segmented into skin tests, blood tests, patch test, and others. The skin test is further segmented into prick or scratch test, intradermal test, and others.<\/p>\n

On the basis of treatments, the market is segmented into antihistamines, corticosteroids, treatment of anaphylaxis, withdrawal of the drug, and others. Antihistamines are further sub-segmented into azelastine eyedrops, azelastine nasal sprays, carbinoxamine, cyproheptadine, desloratadine, diphenhydramine, emedastine eyedrops, hydroxyzine, levocabastine eyedrops, levocabastine oral, and others. Corticosteroids is further sub-segmented into topical steroids, inhaled steroids, and others. Inhaled steroids is further segmented into flunisolide, fluticasone furoate, fluticasone propionate, triamcinolone acetonide, beclomethasone dipropionate, budesonide, and others.<\/p>\n

On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.<\/p>\n

Regional Analysis of the Global Drug Allergy Market    <\/strong>            <\/p>\n

The Americas dominate the global market for the drug allergy. The Americas mainly include North America and Latin America, out of which North America accounts for the majority of the market share of this region. The US is the top revenue generating market in North America and is one of the important markets for the global drug allergy treatment. Approximately 10% of the total US population have drug allergies. Latin America drug allergy market is also growing significantly and mainly includes Brazil, Argentina, and Chile. Europe is the second largest market in the globe owing to increasing cases of drug allergy.<\/p>\n

Europe is mainly divided into Eastern Europe and Western Europe. More developed Western European countries like Germany, UK and France are dominating this market while East European region is also growing significantly. Increasing cases of drug allergies are one of the major factors for the growth of the Europe market.<\/p>\n

Asia Pacific region is showing the fastest growth rate in the global drug allergy market due to some major factors such as increasing awareness about various drug allergies, availability of treatment products, and rapidly improving healthcare facilities. Japan is holding the major market share while China’s drug allergy market is expected to show the fastest growth in this region. Changing healthcare practices and increasing patient involvement play an important role in the growth of this market.<\/p>\n

The Middle East & Africa is expected to experience a limited growth due to lack of awareness about diseases, traditional healthcare practices, etc. The Middle East region dominates the market due to some of the major factors, for instance, developed healthcare facilities and government support to improve public health.<\/p>\n

Apply for Exclusive Discount @ <\/strong>https:\/\/www.marketresearchfuture.com\/check-discount\/4033<\/strong><\/a><\/p>\n

Detailed Table of Contents:<\/strong><\/p>\n

1. Report Prologue<\/strong><\/p>\n

2. Introduction<\/strong><\/p>\n

2.1 Definition<\/p>\n

2.2 Scope Of The Study<\/p>\n

2.2.1 Research Objective<\/p>\n

2.2.2 Assumptions<\/p>\n

2.2.3 Limitations<\/p>\n

2.3 Market Structure<\/p>\n

2.4. Market Segmentation<\/p>\n

3. Research Methodology<\/strong><\/p>\n

3.1 Research Process<\/p>\n

3.2 Primary Research<\/p>\n

3.3 Secondary Research<\/p>\n

3.4 Market Size Estimation<\/p>\n

3.5 Forecast Model<\/p>\n

11. Competitive Landscape<\/strong><\/p>\n

12. Company Profile<\/strong><\/p>\n

13. Conclusion<\/strong><\/p>\n

13.1 Key Findings<\/p>\n

13.1.1 From Ceo’s Viewpoint<\/p>\n

13.1.2 Unmet Needs Of The Market<\/p>\n

13.2 Key Companies To Watch<\/p>\n

13.3 Prediction Of Drug Allergy Market<\/p>\n

14. Appendix<\/strong><\/p>\n

…Continued!<\/strong><\/p>\n

Send An Enquiry @ <\/strong>https:\/\/www.marketresearchfuture.com\/enquiry\/4033<\/strong><\/a><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Market Research Future
Contact Person:<\/strong> Abhishek Sawant
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9312
Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.marketresearchfuture.com<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Drug allergy market information: by type (immunologic, nonimmunologic, and others), diagnosis (skin tests, blood tests, and others), by treatment (antihistamines, corticosteroids, and others), by end user- global forecast till 2023 Synopsis of Global Drug Allergy Market Market Scenario The global … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-254243","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/254243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=254243"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/254243\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=254243"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=254243"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=254243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}